Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alberto Jacobo Cunquero Tomas"'
Autor:
Susana Torres, Eloisa Jantus-Lewintre, Danielle Mirda, Álvaro González, Rafael Sirera, Silvia Calabuig Fariñas, Carlos Camps, Alberto Jacobo Cunquero Tomas, Macarena Ferrero
Publikováno v:
Expert Review of Molecular Diagnostics. 20:575-582
Among non-small cell lung cancer (NSCLC) patients, there is one molecularly defined subgroup harboring activating mutations in the epidermal growth factor receptor gene (Herein we review the clinical development and technical features of cobas® EGFR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26c670e138a08607e6e814e485660cf9
https://doi.org/10.1080/14737159.2020.1724094
https://doi.org/10.1080/14737159.2020.1724094
Autor:
Sebastian Ochenduszko, Javier García, María Jose Juan-Fita, Ines Gonzalez-Barrallo, Julio Herrero Colomina, Robert Diaz Beveridge, Silverio Ros Martinez, Blanca Sanchez Lafuente, Alberto Jacobo Cunquero Tomas, Alfonso Berrocal, Pablo Cerezuela-Fuentes, Pablo Luna Fra, Alicia Gervás Peeters, José Luis Sanchez Gonzalez, Andres Meana Garcia, Mariasun Algarra Garcia, Eugenio Palomares García, Javier Perez Altozano, Mónica Tallón Guerola, Inmaculada Maestu
Publikováno v:
Journal of Clinical Oncology. 40:e21529-e21529
e21529 Background: Previous reports proved the feasibility of immunotherapy (IT) discontinuation in advanced melanoma (MEL) patients (pts) in case of CR. We aimed to investigate clinical characteristics of pts with sustained CR after elective discont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20ce3d7d60ec1c95f01cc54e5073f781
https://doi.org/10.1200/jco.2022.40.16_suppl.e21529
https://doi.org/10.1200/jco.2022.40.16_suppl.e21529
Autor:
María Gutierrez Toribio, José Manuel Sepulveda Sánchez, Alberto Jacobo Cunquero Tomas, Pablo Alvarez-Ballesteros, Ramon De Las Peñas Bataller, Irene Moya Horno, Sergio Peralta Muñoz, Maria Teresa Quintanar Verduguez, Oscar Gallego Rubio, Rosario Sarabia, Sonia Del Barco Berron, Regina Gironés Sarrió, Javier Díaz-Santos, Maria Teresa Tuñón Alvarez, I. Fernández, Isaac Ceballos Lenza, María Ángeles Vaz Salgado, Alejandra Ivars Rubio
Publikováno v:
Journal of Clinical Oncology. 39:e14047-e14047
e14047 Background: Glioblastoma (GBM) is the most common brain primary tumor. Almost all patients have recurrent disease after initial treatment with surgery, radiotherapy and chemotherapy. After disease recurrence, there is no standardized treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d28bf0453b2d00e3c6dc85a5c9cac766
https://doi.org/10.1200/jco.2021.39.15_suppl.e14047
https://doi.org/10.1200/jco.2021.39.15_suppl.e14047
Autor:
Rosario Sarabia, Maria Teresa Quintanar Verduguez, Isaac Ceballos Lenza, Ramon De Las Peñas Bataller, Sergio Peralta Muñoz, María Gutierrez Toribio, José Manuel Sepulveda Sánchez, Sonia Del Barco Berron, Maria Teresa Tuñón Alvarez, I. Fernández, Manuel Benavides, Alejandra Ivars Rubio, Maria Cruz Martin Soberón, Oscar Gallego Rubio, M.A. Vaz, Irene Moya Horno, Regina Gironés Sarrió, Alberto Jacobo Cunquero Tomas
Publikováno v:
Journal of Clinical Oncology. 39:e14046-e14046
e14046 Background: Glioblastoma (GBM) grade IV represents the most frequent and aggressive primary brain tumor. Despite complete surgical resection, GBM infiltrative potential leads to local recurrence rates of around 100%. Standard treatment with ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fd077c479f1a3b8667e46de62d1fafd
https://doi.org/10.1200/jco.2021.39.15_suppl.e14046
https://doi.org/10.1200/jco.2021.39.15_suppl.e14046
Autor:
Ana Gómez, Carlos Camps, Vega Iranzo, Cristina Caballero, I. Shaheen, Maria Jose Godes, Marina Meri Abad, Ana Blasco, Mireia Gil Raga, Miriam Lobo de Mena, I. Ortega, Maria Jose Safont Aguilera, Martín Núñez Abad, Francisco Aparisi, Alberto Jacobo Cunquero Tomas, Amaya Belen Fernandez Diaz, María del Rocío Ramirez Belloch, Milagros Franco de la Rosa, Alfonso Berrocal
Publikováno v:
Journal of Clinical Oncology. 38:11016-11016
11016 Background: Burn-Out Syndrome (BOS) is defined by (1) emotional and physical exhaustion; (2) cynicism and depersonalization; and (3) no personal nor professional fulfillment. It affects up to 78% of oncology-related workers (doctors, nurses and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23c440758d88aba416180edc54950879
https://doi.org/10.1200/jco.2020.38.15_suppl.11016
https://doi.org/10.1200/jco.2020.38.15_suppl.11016
Autor:
Marina Meri Abad, Maria Jose Godes, I. Shaheen, Ana Blasco, Adriana Fernandez, Cristina Caballero, Maria Jose Safont, Claudio Dario Avila Andrade, Alberto Jacobo Cunquero Tomas, Amaya Belen Fernandez Diaz, Alfonso Berrocal, Ferri Pep, Vega Iranzo, Carlos Camps, Lauren Condori Farfan
Publikováno v:
Journal of Clinical Oncology. 35:75-75
75 Background: Comprehensive and continuous care is esential for the correct management of cancer patients. To achieve this, specific programs for early diagnosis and long survivor care are needed. Since 2007, within the project “Oncology beyond th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6503cc9104304ce5aa81864028744dd0
https://doi.org/10.1200/jco.2017.35.8_suppl.75
https://doi.org/10.1200/jco.2017.35.8_suppl.75
Autor:
Gerardo Antonio Umanzor Funez, Ana Blasco, Francisco Javier García Navalón, Alberto Jacobo Cunquero Tomas, Vega Iranzo, Virginia Palomar Coloma, Carlos Camps, Rosa Monfort García
Publikováno v:
Journal of Clinical Oncology. 32:251-251
251 Background: Each year, the prevalence of cancer long survivors (CLS) increases; defined as a person who after five years of diagnosis and treatment is free from disease. Health problems faced by these patients are different from those in general
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f00eaaabc8fa9dad090ece279cdd4242
https://doi.org/10.1200/jco.2014.32.31_suppl.251
https://doi.org/10.1200/jco.2014.32.31_suppl.251